PPD Names Christopher Scully as Executive VP, CFO
8 May 2018 - - Wilmington, North Carolina-based global contract research organization Pharmaceutical Product Development, LLC (PPD) has appointed Christopher Scully as executive vice president and chief financial officer, effective May 15,2018, the company said.
Scully has more than 25 years of experience and extensive financial and commercial expertise in the pharmaceutical industry. He most recently served at Pfizer, Inc. as chief commercial officer for the Pfizer essential health business unit.
In that role, he helped to transform the USD 26bn unit into a sustainably growing business with franchises in multiple durable and growing market segments.
During his 21 years with Pfizer, Scully helped grow and transform several multibillion-dollar businesses through a range of senior roles, including regional president, established products Europe; vice president of finance/CFO, established products business unit; and vice president of finance, both for Japan and Asia and then for Pfizer's worldwide pharmaceutical business.
Scully earned an MBA with a concentration in finance and international business from the Stern School of Business at New York University and a bachelor's degree in electrical engineering from Manhattan College.
PPD provides comprehensive, integrated drug development, laboratory, and lifecycle management services.
Clients and partners include pharmaceutical, biotechnology, medical device, academic, and government organizations. The company has offices in 47 countries and approximately 20,000 professionals worldwide.